[A comparative study in the rat of two routes of administration of 14 c-labeled sodium m-trifluoromethyl-1, 3-diphenyl-4-hydroxymethylene-5-pyrazolone].
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage* / Q000378:metabolism; D001646:Bile / Q000378:metabolism; D002250:Carbon Radioisotopes; D004386:Duodenum; D004764:Enterohepatic Circulation; D005243:Feces / Q000378:metabolism; D007267:Injections; D007441:Intubation, Gastrointestinal; D007700:Kinetics; D008297:Male; D011720:Pyrazoles / Q000008:administration & dosage* / Q000378:metabolism; D051381:Rats; D013997:Time Factors
D000894:Anti-Inflammatory Agents, Non-Steroidal; D002250:Carbon Radioisotopes; D011720:Pyrazoles
Etude comparative chez le rat de deux voies d'administration du sel de sodium de la méta-trifluorométhyl-phényl-1 phényl-3 hydroxy méthylène-4 pyrazolone-5 marqué au 14C